NewsBenzingaTD Cowen maintient sa recommandation d’achat sur Krystal Biotech, abaisse son objectif de cours à 380 $ TD Cowen maintient sa recommandation d’achat sur Krystal Biotech, abaisse son objectif de cours à 380 $ Benzinga 2026.11.03 15:48 (GMT+0) Open on Benzinga Other news How Everyday Investors Are Playing the Nvidia Drama Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares Nvidia promises that revenue will keep soaring — for now CalPERS Discloses $37.1 Million Stake in Strategy
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares